Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
Partnered Content
PDF Library
RSS Feeds
Subscribe
Advertising
Report Store
UsernamePublicRestriction
Tags:
BioPharmaceutical Medical Device Deals

Salix Expects Acquisition Of Oceana, Two Products, To Be Quickly Accretive

This article was originally published in The Pink Sheet Daily

  • News

Executive Summary

Although privately held Oceana’s two products – Solesta and Deflux – are regulated by FDA as Class III medical devices, Salix intends to market them with existing sales forces.

Table

View full table

Advertisement

Related Content

In Vivo
Device and Diagnostics Dealmaking Quarterly Statistics, Q4 2011
Scrip
Start-Up Quarterly Statistics, Q4 2011
Pink Sheet
Amitiza Hits Mark In Confirmatory Opioid-Induced Bowel Dysfunction Study
Pink Sheet
GI Drugs Cmte. To Weigh Retreatment Study Design For Salix's Xifaxan In Irritable Bowel
Medtech Insight
Oceana To Launch Solesta For Fecal Incontinence By September
Pink Sheet
Progenics Finds New Partner For Relistor In Salix

Topics

Related Companies

Advertisement
Tags:
BioPharmaceutical Medical Device Deals
UsernamePublicRestriction

Register

PS073033

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By